Matthew Pulisic
Fortune : 839 507 $ au 30/06/2026
Fortune : 839 507 $ au 30/06/2026
Matthew Pulisic is currently Chief Financial & Accounting Officer at Genelux Corp.
since 2025.
Formerly, Mr. Pulisic was Vice President-Finance at Arrowhead Pharmaceuticals, Inc. from 2020 to 2025.
Education includes an undergraduate degree from the University of California, Santa Cruz and an MBA from California Lutheran University School of Business Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENELUX CORP. 0,62 % | 16/06/2026 | 278 906 ( 0,62 % ) | 839 507 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GENELUX CORPORATION | Directeur Financier/CFO | 30/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/01/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Lutheran University School of Business Management
California Lutheran University School of Business Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national